Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

1970s and 'Patient 0' HIV-1 genomes illuminate early HIV/AIDS history in North America.

Worobey M, Watts TD, McKay RA, Suchard MA, Granade T, Teuwen DE, Koblin BA, Heneine W, Lemey P, Jaffe HW.

Nature. 2016 Nov 3;539(7627):98-101. doi: 10.1038/nature19827. Epub 2016 Oct 26.

2.

Addressing the treatment gap and societal impact of epilepsy in Rwanda--Results of a survey conducted in 2005 and subsequent actions.

Sebera F, Munyandamutsa N, Teuwen DE, Ndiaye IP, Diop AG, Tofighy A, Boon P, Dedeken P.

Epilepsy Behav. 2015 May;46:126-32. doi: 10.1016/j.yebeh.2015.03.028. Epub 2015 Apr 30.

3.

Rabies post-exposure prophylaxis with purified equine rabies immunoglobulin: one-year follow-up of patients with laboratory-confirmed category III rabies exposure in the Philippines.

Quiambao BP, Dy-Tioco HZ, Dizon RM, Crisostomo ME, Teuwen DE.

Vaccine. 2009 Nov 27;27(51):7162-6. doi: 10.1016/j.vaccine.2009.09.036.

PMID:
19925947
4.

Clinical and immunological insights on severe, adverse neurotropic and viscerotropic disease following 17D yellow fever vaccination.

Silva ML, Espírito-Santo LR, Martins MA, Silveira-Lemos D, Peruhype-Magalhães V, Caminha RC, de Andrade Maranhão-Filho P, Auxiliadora-Martins M, de Menezes Martins R, Galler R, da Silva Freire M, Marcovistz R, Homma A, Teuwen DE, Elói-Santos SM, Andrade MC, Teixeira-Carvalho A, Martins-Filho OA.

Clin Vaccine Immunol. 2010 Jan;17(1):118-26. doi: 10.1128/CVI.00369-09. Epub 2009 Nov 11.

5.

Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?

Barrett AD, Teuwen DE.

Curr Opin Immunol. 2009 Jun;21(3):308-13. doi: 10.1016/j.coi.2009.05.018. Epub 2009 Jun 10. Review.

PMID:
19520559
6.

Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960.

Worobey M, Gemmel M, Teuwen DE, Haselkorn T, Kunstman K, Bunce M, Muyembe JJ, Kabongo JM, Kalengayi RM, Van Marck E, Gilbert MT, Wolinsky SM.

Nature. 2008 Oct 2;455(7213):661-4. doi: 10.1038/nature07390.

7.

International laboratory network for yellow fever vaccine-associated adverse events.

Barrett AD, Niedrig M, Teuwen DE.

Vaccine. 2008 Oct 9;26(43):5441-2. doi: 10.1016/j.vaccine.2008.06.025. Epub 2008 Jun 30. No abstract available.

PMID:
18590790
8.

Rabies post-exposure prophylaxis in the Philippines: health status of patients having received purified equine F(ab')(2) fragment rabies immunoglobulin (Favirab).

Quiambao BP, Dytioco HZ, Dizon RM, Crisostomo ME, Laot TM, Teuwen DE.

PLoS Negl Trop Dis. 2008 May 28;2(5):e243. doi: 10.1371/journal.pntd.0000243.

9.

Immune response during adverse events after 17D-derived yellow fever vaccination in Europe.

Bae HG, Domingo C, Tenorio A, de Ory F, Muñoz J, Weber P, Teuwen DE, Niedrig M.

J Infect Dis. 2008 Jun 1;197(11):1577-84. doi: 10.1086/587844.

PMID:
18419548
10.

Evaluation of two yellow fever vaccines for routine immunization programs in Argentina.

Ripoll C, Ponce A, Wilson MM, Sharif N, Vides JB, Armoni J, Teuwen DE.

Hum Vaccin. 2008 Mar-Apr;4(2):121-6. Epub 2007 Oct 26.

PMID:
18382132
11.
12.
13.

Postscript relating to new allegations made by Edward Hooper at The Royal Society Discussion Meeting on 11 September 2000.

Plotkin SA, Teuwen DE, Prinzie A, Desmyter J.

Philos Trans R Soc Lond B Biol Sci. 2001 Jun 29;356(1410):825-9.

14.

Hepatitis A and vaccination.

Teuwen DE.

Arch Inst Pasteur Tunis. 1994 Jul-Oct;71(3-4):549-56. No abstract available.

PMID:
8801857
15.

Correction regarding an adverse reaction to the recombinant hepatitis B vaccine.

Hudson TJ, Shuster J, Teuwen DE, Peetermans J.

J Allergy Clin Immunol. 1993 Sep;92(3):498. No abstract available.

PMID:
8360402
16.

Development of an acellular pertussis vaccine and its administration as a booster in healthy adults.

Ruuskanen O, Noel A, Putto-Laurila A, Pêtre J, Capiau C, Delem A, Vandevoorde D, Simoen E, Teuwen DE, Bogaerts H, et al.

Vaccine. 1991 Feb;9(2):117-21.

PMID:
2058258
17.

Measles, mumps and rubella immunization at nine months in a developing country.

Schoub BD, Johnson S, McAnerney JM, Wagstaff LA, Matsie W, Reinach SG, Vandevoorde D, Andre FE, Teuwen DE.

Pediatr Infect Dis J. 1990 Apr;9(4):263-7.

PMID:
2336312
18.

Response to RIT 4237 oral rotavirus vaccine in human milk, adapted-and soy-formula fed infants.

Zoppi G, Mantovanelli F, Pittschieler K, Delem A, Teuwen DE.

Acta Paediatr Scand. 1989 Sep;78(5):759-62.

PMID:
2556883
19.

A trial of RIT-4237 rotavirus vaccine in 1-month-old infants.

Mutz ID, Krainer F, Deutsch J, Kunz C, Teuwen DE.

Eur J Pediatr. 1989 Jun;148(7):634-5.

PMID:
2545451

Supplemental Content

Loading ...
Support Center